132 related articles for article (PubMed ID: 31167689)
1. [Pexidartinib inhibits the aggregation of monocytes into tumor microenvironment and reduces the number of M2 tumor-associated macrophages].
Li X; Jue L; Wang S; Pang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):307-312. PubMed ID: 31167689
[TBL] [Abstract][Full Text] [Related]
2. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract][Full Text] [Related]
3. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
Valero JG; Matas-Céspedes A; Arenas F; Rodriguez V; Carreras J; Serrat N; Guerrero-Hernández M; Yahiaoui A; Balagué O; Martin S; Capdevila C; Hernández L; Magnano L; Rivas-Delgado A; Tannheimer S; Cid MC; Campo E; López-Guillermo A; Colomer D; Pérez-Galán P
Leukemia; 2021 Sep; 35(9):2635-2649. PubMed ID: 33731849
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.
Sun T; Yang Y; Luo X; Cheng Y; Zhang M; Wang K; Ge C
Oncol Res; 2014; 21(5):227-35. PubMed ID: 24854099
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization.
Yang M; Liu J; Shao J; Qin Y; Ji Q; Zhang X; Du J
Mol Cancer; 2014 Mar; 13():43. PubMed ID: 24580730
[TBL] [Abstract][Full Text] [Related]
6. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
[TBL] [Abstract][Full Text] [Related]
7. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
8. Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes.
Boyd MM; Litscher SJ; Seitz LL; Messing A; Hagemann TL; Collier LS
J Neuroinflammation; 2021 Mar; 18(1):67. PubMed ID: 33685480
[TBL] [Abstract][Full Text] [Related]
9. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization.
Foguer K; Braga Mde S; Peron JP; Bortoluci KR; Bellini MH
Biomed Pharmacother; 2016 Apr; 79():102-11. PubMed ID: 27044818
[TBL] [Abstract][Full Text] [Related]
10. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Benner B; Good L; Quiroga D; Schultz TE; Kassem M; Carson WE; Cherian MA; Sardesai S; Wesolowski R
Drug Des Devel Ther; 2020; 14():1693-1704. PubMed ID: 32440095
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.
Fujimura T; Kakizaki A; Kambayashi Y; Sato Y; Tanita K; Lyu C; Furudate S; Aiba S
Exp Dermatol; 2018 Jan; 27(1):64-70. PubMed ID: 28833504
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.
Umemura N; Saio M; Suwa T; Kitoh Y; Bai J; Nonaka K; Ouyang GF; Okada M; Balazs M; Adany R; Shibata T; Takami T
J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406
[TBL] [Abstract][Full Text] [Related]
13. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
14. The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
BMC Cancer; 2017 Jun; 17(1):404. PubMed ID: 28583114
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Differentiation of Tumor-Associated Macrophages from Monocyte Precursors with Modified Melanoma-Conditioned Medium.
Wang T; Kaufman RE
Methods Mol Biol; 2021; 2265():119-128. PubMed ID: 33704710
[TBL] [Abstract][Full Text] [Related]
16. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
17. An
Mason CA; Kossatz S; Carter LM; Pirovano G; Brand C; Guru N; Pérez-Medina C; Lewis JS; Mulder WJM; Reiner T
J Nucl Med; 2020 Mar; 61(3):433-436. PubMed ID: 31420495
[TBL] [Abstract][Full Text] [Related]
18. Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
De Beule N; De Veirman K; Maes K; De Bruyne E; Menu E; Breckpot K; De Raeve H; Van Rampelbergh R; Van Ginderachter JA; Schots R; Van Valckenborgh E; Vanderkerken K
J Pathol; 2017 Mar; 241(4):534-546. PubMed ID: 27976373
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.
Gabrusiewicz K; Hossain MB; Cortes-Santiago N; Fan X; Kaminska B; Marini FC; Fueyo J; Gomez-Manzano C
Neoplasia; 2015 Apr; 17(4):374-84. PubMed ID: 25925380
[TBL] [Abstract][Full Text] [Related]
20. Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA; Chawla PA
Anticancer Agents Med Chem; 2021; 21(12):1510-1519. PubMed ID: 33143617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
